Sumit Majumdar, MD, MPH

Publications

BioMed Experts Profile

Dr. Sumit (Me2) Majumdar is an Associate Professor in the Department of Medicine, University of Alberta; a Research Fellow at the Institute of Health Economics; and a Visiting Instructor in the Department of Ambulatory Care and Prevention, Harvard Medical School. He is also a Population Health Investigator of the Alberta Heritage Foundation for Medical Research and a New Investigator of the Canadian Institutes of Health Research.

Sumit received his MD in 1992 from the University of Alberta, followed by 5 years of clinical training in general internal medicine, and then went on to a combined MPH and research fellowship at Harvard Medical School. His research supervisors were Dr. Stephen Soumerai and Dr. Robert Fletcher. He then returned to the University of Alberta for his first faculty appointment in 1999. Sumit is a health outcomes researcher whose primary interests are related to evaluating and optimizing the management of chronic disease, typified by diabetes mellitus. He has a specific interest and expertise in improving evidence-based prescribing and understanding the barriers that exist to the delivery of quality care. He recently synthesized this vast literature in a chapter of Strom’s Pharmacoepidemiology. In addition, he is a practicing academic internist, taking care of both inpatients and outpatients.

Under the ACHORD umbrella, Sumit is involved in a number of projects related to studying and improving the quality of diabetes management, with a particular focus on evidence-based prescribing. With several other ACHORD investigators, he is using administrative databases to examine patterns of practice and outcomes related to drug treatments of diabetes. With other DOVE investigators, he is evaluating (in a prospective controlled trial) the use of a diabetes outreach program to improve the outcomes for rural patients with type-2 diabetes. With other STRIP-Type2 investigators, he is studying the policy impact (in a randomized controlled trial) of providing free glucose testing strips on the level of glucose control attained in the community.